Sort
82,697 grants matching “vaccine development”
Coxiella burnetii immunobiology, host-pathogen modeling, and countermeasure development
$1,494,396Carrie Mae Long · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Task V32: Manufacturing and Characterization Services for Universal Influenza Vaccines.
$1,494,007Sangeetha Sagar · International Aids Vaccine Initiative · N01 · FY2023 · AI
Cellular Vaccines for Cancer Therapy
$1,493,946University Of Michigan At Ann Arbor · P01 · FY2004 · CA
DEVELOPMENT OF SAPONIN DMLT ADJUVANT (SDA)
$1,493,832Elizabeth Norton · Tulane University Of Louisiana · N01 · FY2025 · AI
Role of inflammation, innate resistance, and immunity in carcinogenesis.
$1,493,249Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Structural Biology Of Virus Assembly
$1,493,212Alasdair C. Steven · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2018 · AR
San Francisco Bay Clinical Trials Unit
$1,493,196Susan Buchbinder · Public Health Foundation Enterprises · UM1 · FY2018 · AI
Lactoferrin as an Adjuvant for Cellular Immunity
$1,493,024Jeffrey K Actor · Pharmareview Corporation · R42 · FY2009 · AI
Vaccine and Treatment Evaluation Units
$1,492,854Nadine Georges Rouphael · Emory University · UM1 · FY2022 · AI
ETIB Clinical Research Core
$1,492,154Ronald Gress · Division Of Basic Sciences - Nci · ZID · FY2015 · CA
UPR/MDACC: Partnership for Excellence in Cancer Research (2 of 2)
$1,491,986Brad R Weiner · University Of Puerto Rico Med Sciences · U54 · FY2022 · CA
PItt-Ohio State-Georgetown Clinical Trials Unit
$1,491,683John W Mellors · University Of Pittsburgh At Pittsburgh · UM1 · FY2017 · AI
PItt-Ohio State-Georgetown Clinical Trials Unit
$1,491,683John W Mellors · University Of Pittsburgh At Pittsburgh · UM1 · FY2016 · AI
Coccidiodes immitis Genome Sequencing Project
$1,491,588Institute For Genomic Research · U01 · FY2001 · AI
Development and Manufacture of Adjuvants for Vaccines Targeting MDR Tuberculosis
$1,491,583Rhea N Coler · Access To Advanced Health Institute · U01 · FY2009 · AI
Chicago Clinical Trials Unit
$1,491,481Babafemi O Taiwo · Northwestern University At Chicago · UM1 · FY2018 · AI
Chicago Clinical Trials Unit
$1,491,481Robert L. Murphy · Northwestern University At Chicago · UM1 · FY2016 · AI
New class of PBP inhibitors to address PBP2-mediated resistance in Neisseria gonorrhoeae
$1,491,415Denis Marc Daigle · Venatorx Pharmaceuticals, Inc. · R01 · FY2019 · AI
Immunology And Pathology Of Murine Leukemia Virus Infections
$1,491,179Kim Hasenkrug · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
TNPRC Breeding Colony Expansion in Support of COVID-19 Research
$1,490,575Lee Hamm · Tulane University Of Louisiana · P51 · FY2021 · OD
San Francisco Bay Clinical Trials Unit
$1,490,310Susan Buchbinder · Public Health Foundation Enterprises · UM1 · FY2017 · AI
WASHINGTON UNIVERSITY AIDS CLINICAL TRIALS UNIT
$1,490,118David B Clifford · Washington University · U01 · FY2007 · AI
Immune Regulation in Mycobacterial and Fungal Infections
$1,489,921Daniel Barber · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Complete Genome Variation in Africans with Extreme HIV-1 Transmission Phenotypes
$1,489,907Jairam Rao Lingappa · University Of Washington · R01 · FY2012 · AI
Influenza Vaccine Development
$1,489,572Gary J Nabel · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI